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Summary The hepatic perfusion index, the ratio of hepatic arterial to total liver blood flow, was measured in
50 consecutive patients with colorectal cancer using radiolabelled colloid with high administered activity. In
patients with proven liver metastases the diagnostic sensitivity of the HPI was 96% and the predictive value of
a negative test was 92%. Dynamic hepatic scintigraphy is of value in the management of patients with
colorectal cancer.
Dynamic hepatic scintigraphy can provide an estimate of the
relative proportion of hepatic arterial to total liver blood
flow (the hepatic perfusion index, HPI). It has been claimed
to identify up to 96% of patients with colorectal liver metas-
tases when the HPI is abnormal. If this is correct it is to date
the only technique which has the potential to identify those
patients with subclinical hepatic metastases (Leveson et al.,
1985; Parkin et al., 1983). Despite this, dynamic hepatic
scintigraphy has not been accepted into routine clinical prac-
tice. Some investigators have failed to confirm the initially
encouraging reports from Parkin et al. (Ballantyne et al.,
1990), whilst others have found significant uncertainties in
the curve analysis produced by low count rates (Leng et al.,
1987; Goldberg et al., 1989). In an attempt to circumvent
these problems we undertook a pilot study using radio-
labelled colloid with a high administered activity together
with image processing using Parkin's technique (Parkin et al.,
1983) and have achieved a good intra- and inter-observer
reproducibility and reliability of dynamic hepatic scintig-
raphy (Hemingway et al., 1991b). We now present our
experience of dynamic hepatic scintigraphy using this
modified technique in 50 consecutive patients with colorectal
carcinoma.
Patients and methods
Fifty consecutive patients presenting with colorectal cancer
underwent dynamic hepatic scintigraphy. Each patient fasted
for 12 h, was positioned supine over a large field of view
gamma camera and given a rapid intravenous bolus injection
of 400 MBq 99'Tc albumin colloid in a volume of 2 ml via an
antecubital vein. Posterior images were obtained every 2 sec
for 2 min on a 64 by 64 matrix using a large field of view
gamma camera (IGE 400A) fitted with a high sensitivity
parallel hole collimator and interfaced to a Link Analytical
MAPS computer. Regions of interest were drawn around the
liver and both kidneys avoiding overlap with the lungs, aorta
or spleen and time-activity curves constructed. The curves
were analysed according to the method described by Perkins
et al. (1987). Using the left renal artery peak (Tp) as the
demarcation of the hepatic arterial and portal venous com-
ponents of liver perfusion, the gradients of the 8 sec periods
immediately before (G1) and after Tp (G2) were calculated
using a least squares regression analysis, excluding the frame
immediately overlapping Tp. The hepatic perfusion index was
expressed as the ratio of the hepatic arterial gradient to the
total liver blood flow gradients, i.e.
HPI = GI/(GI + G2).
The upper limit of normal for this technique when using the
left kidney has been reported as 0.37 (Perkins et al., 1987)
and this value was used for this investigation as ethical
permission was not available to study patients without
cancer.
At the end of the dynamic study a standard six view static
liver scan was carried out. In addition a computerised tomo-
gram and ultrasound scan was obtained. An intraoperative
ultrasound was performed where appropriate as well as
bimanual palpation at laparotomy to identify liver metas-
tases. Liver tumour deposits were biopsied where possible.
The dynamic hepatic scintigraphy studies and the static
images were reported without knowledge of the results of
other imaging modalities.
The results are the mean of two complete reprocessings of
each study by one observer (DMH), including redrawing of
regions of interest.
Results
Fifty patients entered the study. One study was unproces-
sable since there was complete overlap of the lung and right
renal images over the hepatic image leaving 49 studies for
analysis. No studies had to be rejected from analysis because
of poor count statistics in any region of interest.
Twenty four patients had confirmed hepatic metastases. In
eight the hepatic metastases were confirmed histologically
and in a further eight patients the diagnosis was confirmed
by a combination of palpation at laparotomy, CT scanning
with or without conventional ultrasound or intraoperative
ultrasound. In six patients the diagnosis was established by
CT and ultrasound scanning and in two by CT alone.
Twenty five patients had no evidence of hepatic metastases
using any of the above tests at presentation.
The HPI was abnormally elevated (greater than 0.37) in 23
and the static images were considered abnormal in 19 of
these 24 patients with established liver metastases. Of the 25
with no evidence of liver metastases at presentation, the HPI
was elevated in 11 and was normal in another 14. Static
scanning showed apparent liver metastases in five and was
normal in 20 of these 25 patients. The results of HPI and
static scanning are shown in Figure 1.
In patients with proven liver metastases the diagnostic
sensitivity of the HPI was 96% and for static scintigraphy
79%. The negative predictive values for dynamic and static
scintigraphy were 93% and 80% respectively. The sensitivity,
specificity, positive and negative predictive value of an
elevated HPI or a positive static scan in the diagnosis of
overt hepatic metastases are shown in Table I.
Correspondence: T.G.Cooke, University Department of Surgery, The
Royal Infirmary, Glasgow, UK.
Received 1 August 1991; and in revised formn 12 November 1991.













Liver metastases No liver metastases
Figure 1 The hepatic perfusion index and static scintigraphy in
patients with overt hepatic tumours and apparently normal livers.
O Positive static scan; * Negative static scan.
Table I The hepatic perfusion index and static scintigraphy in patients
with overt colorectal liver metastases
HPI Static scintigraphy
Number Percentage Number Percentage
Sensitivity 23 96% 19 79%
24 24
Specificity 14 56% 19 80%
25 24
Positive predictive 23 68% 19 79%
value 34 24
Negative predictive 14 93% 20 80%
value 15 25
Discussion
Compared to normal hepatic parenchyma, colorectal liver
metastases derive a greater proportion of their blood supply
from the hepatic artery than from the portal vein (Breedis &
Young, 1954). In addition our experimental work has dem-
onstrated that portal venous inflow is reduced in the presence
of hepatic metastases and that this causes an increase in the
hepatic perfusion index, the ratio of hepatic arterial to total
liver blood flow, which can be detected by dynamic hepatic
scintigraphy (Hemingway et al., 1991a). The combination of
static and dynamic hepatic scintigraphy can identify the
majority of patients with hepatic metastases (Leveson et al.,
1985).
In addition to treatment for the primary tumour, this unit
offers hepatic resection for solitary or unilobar hepatic
metastases, or regional chemotherapy if hepatic metastases
are widespread or unresectable. The relatively high propor-
tion of patients with established liver metastases at presenta-
tion is a reflection of our referral pattern. We used a high
administered activity (400 MBq) to improve count statistics
in each region of interest (Hemingway et al., 1991b). This
resulted in a low rejection rate for unprocessable studies. The
hepatic perfusion index was abnormally elevated in 23 of 24
patients with hepatic metastases. This confirms Leveson's
original observations and contrasts with another study in
which only 63% of patients with overt hepatic metastases
had an elevated HPI (Leveson et al., 1985; Ballantyne et al.,
1990).
Leveson reported that an elevated HPI in the presence of
an apparently normal liver was highly suggestive of occult
hepatic metastases undetectable by any other imaging
modality. We too have confirmed that the HPI is abnormal
in some patients with an apparently normal liver. Clinical
follow up will determine whether the abnormal HPI values in
these patients are false positives or are due to occult metas-
tases which will become apparent with time and these
patients are being closely monitored. If this hypothesis is
correct the true specificity, positive and negative predictive
values of the technique will be higher than the values we
have obtained at present.
There is interest currently in adjuvant chemotherapy for
patients with colorectal cancer (Taylor et al., 1985). Dynamic
hepatic scintigraphy may be able to identify those patients
who are most likely to benefit from such an approach whilst
avoiding the exposure of patients at low risk of metastases to
such a regime.
In contrast to other groups (Ballantyne et al., 1990), we
have been able to reproduce Leveson's results for dynamic
hepatic scintigraphy in patients with colorectal cancer using a
high administered activity and Parkin's technique of image
analysis. We believe that dynamic hepatic scintigraphy may
be of value in the management of patients with colorectal
carcinoma.
Work in our department is funded by the Cancer Research Cam-
paign.
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